Clinics in chest medicine

Publisher: WB Saunders

Journal description

Current impact factor: 2.17

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 2.168
2012 Impact Factor 2.066
2011 Impact Factor 3.284
2010 Impact Factor 3.11
2009 Impact Factor 2.505
2008 Impact Factor 2.357
2007 Impact Factor 1.858
2006 Impact Factor 1.991
2005 Impact Factor 1.456
2004 Impact Factor 1.65
2003 Impact Factor 1.308
2002 Impact Factor 2.026
2001 Impact Factor 1.891
2000 Impact Factor 1.627
1999 Impact Factor 2.042
1998 Impact Factor 1.316
1997 Impact Factor 1.307
1996 Impact Factor 1.133
1995 Impact Factor 1.105
1994 Impact Factor 1.027
1993 Impact Factor 0.972
1992 Impact Factor 1.785

Impact factor over time

Impact factor

Additional details

5-year impact 2.19
Cited half-life 8.20
Immediacy index 0.41
Eigenfactor 0.00
Article influence 0.71
Other titles Clinics in chest medicine (Online), Clinics in chest medicine
ISSN 1557-8216
OCLC 40612530
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

WB Saunders

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Pre-print allowed on any website or open access repository
    • Voluntary deposit by author of authors post-print allowed on institutions open scholarly website including Institutional Repository, without embargo, where there is not a policy or mandate
    • Deposit due to Funding Body, Institutional and Governmental policy or mandate only allowed where separate agreement between repository and the publisher exists.
    • Permitted deposit due to Funding Body, Institutional and Governmental policy or mandate, may be required to comply with embargo periods of 12 months to 48 months .
    • Set statement to accompany deposit
    • Published source must be acknowledged
    • Must link to journal home page or articles' DOI
    • Publisher's version/PDF cannot be used
    • Articles in some journals can be made Open Access on payment of additional charge
    • NIH Authors articles will be submitted to PubMed Central after 12 months
    • Authors who are required to deposit in subject-based repositories may also use Sponsorship Option
    • 'WB Saunders' is an imprint of 'Elsevier'
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Interstitial lung disease (ILD) is a clinical syndrome of various etiologies and histopathologic categorization that, when clinically significant, impair respiratory function. Patients with ILD may develop critical illness from respiratory failure, nonpulmonary organ failure, or after surgical procedures. Additionally, the intensivist must be adept at recognizing exacerbation syndromes, which can complicate the disease course of some forms of ILD. This article discusses mechanical ventilation, noninvasive mechanical ventilation, exacerbation syndromes, and surgical concerns for patients with ILD who are critically ill. Published by Elsevier Inc.
    Clinics in chest medicine 09/2015; 36(3):497-510. DOI:10.1016/j.ccm.2015.05.012
  • [Show abstract] [Hide abstract]
    ABSTRACT: Targeted temperature management has an established role in treating the post-cardiac arrest syndrome after out-of-hospital cardiac arrest with an initial rhythm of ventricular tachycardia/ventricular fibrillation. There is less certain benefit if the initial rhythm is pulseless electrical activity/asystole or for in-hospital cardiac arrest. Targeted temperature management may have a role as salvage modality for conditions causing intracranial hypertension, such as traumatic brain injury, hepatic encephalopathy, intracerebral hemorrhage, and acute stroke. There is variable evidence for its use early in these disorders to minimize secondary neurologic injury. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 09/2015; 36(3):385-400. DOI:10.1016/j.ccm.2015.05.011
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clinicians working in the intensive care unit (ICU) confront death and dying daily. ICU care can be inconsistent with a patient's values, preferences, and previously expressed goals of care. Current evidence promotes the integration of palliative care services within the ICU setting. Palliative care bridges the gap between comfort and cure, and these services are growing in the United States. This article discusses the benefits and barriers to integration of ICU and palliative care services, and a stepwise approach to implementation of palliative care services. Integration of palliative care services into ICU workflow is increasingly seen as essential to providing high-quality, comprehensive critical care. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 09/2015; 36(3):441-8. DOI:10.1016/j.ccm.2015.05.010
  • [Show abstract] [Hide abstract]
    ABSTRACT: Patients in the intensive care unit are at high risk for experiencing adverse events and errors. The high-acuity health care needs of these vulnerable patients expose them to numerous medications, procedures, and health care providers. The occurrence of adverse events is associated with detriments to patient outcomes including increased mortality. Adverse event reporting is the most commonly used event-detection tool, but it should also be complimented with other tools such as trigger tools, chart review, and direct observation. Although adverse event reporting is essential for continuous improvement processes and is associated with improvements in safety culture, it remains significantly underutilized. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 09/2015; 36(3):461-7. DOI:10.1016/j.ccm.2015.05.005
  • Clinics in chest medicine 09/2015; 36(3):xv-xvi. DOI:10.1016/j.ccm.2015.07.002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clinical reasoning in medicine describes the process whereby a clinician gathers, assimilates, and assesses information about a person and their illness to assign a diagnosis and institute therapy. Care of patients in the intensive care unit involves managing a substantial quantity of incomplete, novel, and rapidly changing data. A modified nine-step bayesian approach to clinical reasoning comports well with this complex environment and is useful for assisting and educating novice learners to apply clinical reasoning accurately and consistently. When combined with a sophisticated approach to risk-benefit analysis to modify the treatment threshold, it becomes a useful and insightful tool for clinicians and those working in medical education. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 09/2015; 36(3):449-59. DOI:10.1016/j.ccm.2015.05.016
  • [Show abstract] [Hide abstract]
    ABSTRACT: ICU-acquired weakness is a common problem and carries significant morbidity. Despite evidence that early mobility can mitigate this, implementation outside of the research setting is lagging. Understanding barriers at the systems as well as individual level is a crucial step in successful implementation of an ICU mobility program. This includes taking inventory of waste, overburden and inconsistencies in the work environment. Appreciating regulative, normative as well as cultural forces at work is critical. Finally, key personnel, which include organizational leaders, innovation champions and end users of the proposed change need to be accounted for at each step during program implementation. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 09/2015; 36(3):431-40. DOI:10.1016/j.ccm.2015.05.006
  • [Show abstract] [Hide abstract]
    ABSTRACT: Extracorporeal membrane oxygenation (ECMO) has been available for decades, with its use steadily expanding in the setting of advances in technology. The most common indications for venovenous and venoarterial ECMO remain severe hypoxemic respiratory failure and cardiogenic shock, respectively. Refinements in extracorporeal circuitry and cannulation strategies have led to novel indications for ECMO in cardiopulmonary failure, including pulmonary hypertension, extracorporeal cardiopulmonary resuscitation, and less severe forms of the acute respiratory distress syndrome. There is hope for the development of destination device therapy, which could have significant implications for acute and chronic management of severe respiratory and cardiac disease. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 06/2015; 36(3). DOI:10.1016/j.ccm.2015.05.014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Infections with multidrug-resistant organisms (MDROs) are common in critically ill patients and are challenging to manage appropriately. Strategies that can be used in the treatment of MDRO infections in the intensive care unit (ICU) include combination therapy, adjunctive aerosolized therapy, and optimization of pharmacokinetics with higher doses or extended-infusion therapy as appropriate. Rapid diagnostic tests could assist in improving timely appropriate antimicrobial therapy for MDRO infections in the ICU. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 06/2015; 36(3). DOI:10.1016/j.ccm.2015.05.007
  • [Show abstract] [Hide abstract]
    ABSTRACT: During the last 15 years, critical care services provided via telemedicine have expanded to now be incorporated into the care of 13% of patients in intensive care units (ICUs) in the United States. A response to shortfalls in the availability of critical care-trained providers has evolved into integrated programs of ICU care with contributions to improved outcomes through proactive management, population oversight, and standardization of care processes. The most impactful characteristics of successful ICU telemedicine programs are now better understood with more than a decade of national experience and the accrued benefits to health care systems. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 06/2015; 36(3). DOI:10.1016/j.ccm.2015.05.004
  • [Show abstract] [Hide abstract]
    ABSTRACT: Diffuse cystic and nodular lung diseases have characteristic imaging findings. The most common causes of cystic lung disease are lymphangioleiomyomatosis and Langerhans cell histiocytosis. Other less common cystic lung diseases include Birt-Hogg-Dube syndrome, lymphocytic interstitial pneumonitis, and light chain deposition disease. Computed tomography is used to differentiate cystic lung disease from emphysema, honeycombing, cavities, and bronchiectasis, which mimic cystic lung disease. Diffuse nodular lung disease are categorized as centrilobular, perilymphatic, and random types. In diffuse nodular lung disease, a specific diagnosis is achieved through a combination of history, physical examination, and imaging findings. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 04/2015; 36(2). DOI:10.1016/j.ccm.2015.02.011
  • [Show abstract] [Hide abstract]
    ABSTRACT: High-resolution chest computed tomography (CT) is one of the most useful techniques available for imaging bronchiolitis because it shows highly specific direct and indirect imaging signs. The distribution and combination of these various signs can further classify bronchiolitis as either cellular/inflammatory or fibrotic/constrictive. Emphysema is characterized by destruction of the airspaces, and a brief discussion of imaging findings of this class of disease is also included. Typical CT findings include destruction of airspace, attenuated vasculatures, and hyperlucent as well as hyperinflated lungs. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 04/2015; 36(2). DOI:10.1016/j.ccm.2015.02.013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Computed tomography (CT) is central to the detection and diagnosis of a wide variety of pulmonary, cardiovascular, and other diseases of the chest. Successful interpretation of thoracic CT requires both an appreciation of the spectrum of normal appearances of the chest and a systematic approach to the characterization of thoracic pathology. This article provides an introduction to basic CT techniques and protocols, a review of normal CT anatomy, and an overview of commonly encountered abnormalities. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 04/2015; 36(2). DOI:10.1016/j.ccm.2015.02.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: Occupational and environmental lung disease remains a major cause of respiratory impairment worldwide. Despite regulations, increasing rates of coal worker's pneumoconiosis and progressive massive fibrosis are being reported in the United States. Dust exposures are occurring in new industries, for instance, silica in hydraulic fracking. Nonoccupational environmental lung disease contributes to major respiratory disease, asthma, and COPD. Knowledge of the imaging patterns of occupational and environmental lung disease is critical in diagnosing patients with occult exposures and managing patients with suspected or known exposures. Copyright © 2015 Elsevier Inc. All rights reserved.
    Clinics in chest medicine 04/2015; 36(2). DOI:10.1016/j.ccm.2015.02.008
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although primarily a lung disease, chronic obstructive pulmonary disease (COPD) is now recognized to have extrapulmonary effects on distal organs, the so-called systemic effects and comorbidities of COPD. Skeletal muscle dysfunction, nutritional abnormalities including weight loss, cardiovascular complications, metabolic complications, and osteoporosis, among others, are all well-recognized associations in COPD. These extrapulmonary effects add to the burden of mortality and morbidity in COPD and therefore should be actively looked for, assessed, and treated.
    Clinics in chest medicine 03/2014; 35(1):101-130. DOI:10.1016/j.ccm.2013.10.007
  • [Show abstract] [Hide abstract]
    ABSTRACT: Alpha1-antitrypsin (AAT) deficiency was first described in 1963 together with its associations with severe early-onset basal panacinar emphysema. The genetic defects leading to deficiency have been elucidated and the pathophysiologic processes, clinical variation in phenotype, and the role of genetic modifiers have been recognized. Strategies to increase plasma (and hence tissue) concentrations of AAT have been developed. The only recognized specific therapeutic strategy is regular infusions of the purified plasma protein, and evidence confirms its efficacy in protecting the lung (at least partially). Early detection and modification of lifestyle remains crucial to the management of AAT deficiency.
    Clinics in chest medicine 03/2014; 35(1):39-50. DOI:10.1016/j.ccm.2013.10.001
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic obstructive pulmonary disease (COPD) is currently defined as a common preventable and treatable disease that is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to the overall severity in individual patients. The evolution of this definition and the diagnostic criteria currently in use are discussed. COPD is increasingly divided in subgroups or phenotypes based on specific features and association with prognosis or response to therapy, the most notable being the feature of frequent exacerbations.
    Clinics in chest medicine 03/2014; 35(1):1-6. DOI:10.1016/j.ccm.2013.10.010
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic obstructive pulmonary disease is associated with chronic inflammation affecting predominantly lung parenchyma and peripheral airways and results in largely irreversible and progressive airflow limitation. This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, and T lymphocytes, which are recruited from the circulation. Oxidative stress plays a key role in driving this inflammation. The pulmonary inflammation may enhance the development and growth of lung cancer. The peripheral inflammation extends into the circulation, resulting in systemic inflammation with the same inflammatory proteins. Systemic inflammation may worsen comorbidities. Treatment of pulmonary inflammation may therefore have beneficial effects.
    Clinics in chest medicine 03/2014; 35(1):71-86. DOI:10.1016/j.ccm.2013.10.004